logo
logo

Bigfoot Biomedical® Closes Series C Financing with $55 Million as Company Readies for FDA Submission of Bigfoot Unity

Jun 02, 2020•over 5 years ago

Amount Raised

$55 Million

Round Type

series c

Milpitas

Description

Bigfoot Biomedical, Inc. announced today that the company has raised a total of $55 million to close its Series C equity financing. The round was led by Abbott with support from existing investors, including Quadrant Capital Advisors, Senvest Capital, Janus Henderson and Cormorant Asset Management, along with new investors including Smile Group.

Company Information

Company

Bigfoot

Location

Milpitas, California, United States

About

Bigfoot Biomedical was founded by a team of people with personal connections to Type 1 and Type 2 diabetes and, with its Bigfoot Unity and Bigfoot Autonomy programs, seeks to change the paradigm of care for insulin-requiring diabetes by leveraging data, connectivity, automation, and machine learning to reduce the burden on people with insulin-requiring diabetes and maximize the leverage of health care providers. Learn more at bigfootbiomedical.com. Follow us on Twitter @BigfootBiomed and Facebook.

Related People

Funding Insights

Based on industry data
Tech investment trends
83% of B2B companies plan digital investments, with 79% prioritizing customer experience tech